8P Genomic variants associated with interstitial lung disease in patients treated with trastuzumab-deruxtecan: Results from the PROCURE project
Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), María Isabel Gallegos Sancho(MD Anderson Cancer Center Madrid), María José Echarri, Guillermo Villacampa(Vall d'Hebron Institut de Recerca), J. Cruz Jurado(Hospital Universitario de Canarias), C. Saura Manich(Vall d'Hebron Hospital Universitari), A. Falcon Gonzalez(Hospital Universitario Virgen del Rocío), C. Hinojo González(Marqués de Valdecilla University Hospital), Tyler J. Curiel(Tulane University), E.M. Ciruelos(Hospital Universitario 12 De Octubre), J. Cortés, Johny Nicolas(Cardiovascular Institute of the South), M. Gion Cortes(Hospital Universitario Ramón y Cajal), A. López de Sá(Hospital Clínico San Carlos), Alberto M. Arenas(Instituto de Investigaciones Biomédicas Sols-Morreale), E. Llabrés Valentí(Hospital Universitario Insular de Gran Canaria), Juan Miguel Cejalvo(Universitat de València)
Cited by 0
Related Papers
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
|Cancer Research|2016|399
Combined autophagy and HDAC inhibition
|Autophagy|2014|292